MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Gait during turning associates with imbalance and falls in PD: 3D Video based analysis from a single camera

    JH. Shin, HY. Jeon, B. Jin, SM. Lee, KA. Woo, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the relationship between gait parameters during turning and postural imbalance and falls in Parkinson's disease (PD). Background: It is…
  • 2023 International Congress

    Integrating care coordination into telemedicine services provides a better patient experience than care coordination alone: Insights from a national neurodegenerative disease telemedicine program

    J. Hatcher-Martin, C. Byrne, E. Anderson (Chicago, USA)

    Objective: To develop a comprehensive model of remote care for patients diagnosed with Parkinson’s disease (PD). Background: Recent data suggests that the incidence of new…
  • 2023 International Congress

    Why Me Why Not? Understanding the Perception of Research among African Americans with PD

    C. Branson, J. Luc-Rolland, D. Geiger, J. Cook, A. Willis (Atlanta, USA)

    Objective: To recognize the barriers of participating in PD research with qualitative and quantitative data. Background: Women, minorities, and people over 70 years of age…
  • 2023 International Congress

    Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial

    D. Kern, S. Isaacson, S. Dhanani, J. Aldred, B. Bergmans, D. Santos-Garcia, T. Oeda, F. Gandor, P. Kukreja, L. Bergmann, R. Gupta, S. Talapala, A. Spiegel, T. Kimber (Aurora, USA)

    Objective: Evaluate the frequency of adverse events over time with foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (PD) in a phase 3, open-label safety…
  • 2023 International Congress

    The long and short of contemporary parkinsonism survival: A 47-year clinicopathological study

    E. Noyes, AH. Rajput, A. Rajput (Saskatoon, Canada)

    Objective: We report a 47-year survival study of autopsy verified Parkinson syndrome (PS) and Parkinson’s disease (PD) cases. The objectives were: 1) to identify PS…
  • 2023 International Congress

    Disease progression in Parkinson‘s disease patients with Mild Cognitive Impairment: 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

    X. Deng, S. Saffari, S. Ng, N. Chia, X. Choi, D. Heng, B. Xiao, Z. Xu, K. Tay, W. Au, N. Liu, E. Tan, L. Tan (Singapore, Singapore)

    Objective: To investigate motor, non-motor and cognition progression in early PD patients with Mild Cognitive Impairment (MCI) and normal cognition over 5 years.    Background:…
  • 2023 International Congress

    Real-World Outcomes with Directional Deep Brain Stimulation (DBS) Systems: Awake versus Asleep Lead Placement

    J. Vesper, G. Deuschl, L. Chen, R. Jain (Düsseldorf, Germany)

    Objective: In this report, we compared real-world outcomes of Parkinson's disease (PD) patients using Deep Brain Stimulation (DBS) Systems based on patients being awake or…
  • 2023 International Congress

    Risk of Depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population

    F. Hojjati Pour, M. Salari, H. Pakdaman, M. Etemadifar, N. Mirjamali, M. Khalkhali, A. Farahani (Teheran, Islamic Republic of Iran)

    Objective: We aim to evaluate the prevalence of depression in disorders including multiple sclerosis (MS), Parkinson's disease (PD), migraine, and stroke. Also, we detect risk…
  • 2023 International Congress

    Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study – results of the Belgian subgroup

    V. van Iseghem, N. de Klippel, PH. Bourgeois, P. Bourgeois, T. Warlop, S. Dethy, E. Parmentier, D. Uyttersprot, K. Onuk, G. Garraux (Kortrijk, Belgium)

    Objective: The primary objective of the study was to evaluate the proportion of Parkinson’s Disease (PD) patients in Movement Disorder Centers with Advanced Parkinson’s Disease…
  • 2023 International Congress

    Impact of globus pallidus interna deep brain stimulation on REM sleep behavior disorder in Parkinson’s disease

    A. Mahes, A. Wiltshire, S. Wang, J. Zuzuarregui (San Francisco, USA)

    Objective: The aim of this study was to determine if there is an improvement in rapid eye movement (REM) sleep behavior disorder (RBD) for patients…
  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley